Elena V Fedorova

US Patent:

20100184867, Jul 22, 2010

Filed:

May 13, 2008

Appl. No.:

12/664124

Inventors:

Christelle Lasserre - Jersey City NJ, US
Elena Fedorova - Whippany NJ, US
Yannick Maestro - Martigues, FR

Assignee:

CHANEL PARFUMS BEAUTE - Neuilly Sur Seine

International Classification:

A61K 8/34
A61Q 19/08

US Classification:

514724

Abstract:

A cosmetic process for caring for human skin, which is intended for preventing and/or combating at least one sign of ageing of the skin or the ‘orange peel’ appearance of the skin, includes the topical application to the skin of a composition containing at least one active agent for stimulating the expression of FN3K and/or FN3K RP. The use of this active agent for preventing and/or combating at least one sign of ageing of the skin or the ‘orange peel’ appearance of the skin associated with cellulite is also disclosed.

US Patent:

20120237933, Sep 20, 2012

Filed:

Apr 30, 2012

Appl. No.:

13/459579

Inventors:

Christelle LASSERRE - Jersey City NJ, US
Elena FEDOROVA - Whippany NJ, US
Yannick MAESTRO - Martigues, FR

Assignee:

CHANEL PARFUMS BEAUTE - Neuilly Sur Seine

International Classification:

G01N 21/64

US Classification:

435 611

Abstract:

A method for screening active agents capable of treating at least one cutaneous sign of aging. The agents are identified based on their ability to stimulate fructosamine-3-kinase (FN3K) and/or fructosamine-3-kinase-related protein (FN3K RP) expression.

US Patent:

20120237941, Sep 20, 2012

Filed:

Dec 3, 2010

Appl. No.:

13/514435

Inventors:

Elena Fedorova - Whippany NJ, US

Assignee:

CHANEL PARFUMS BEAUTE - Neuilly sur Seine

International Classification:

C12Q 1/68
G01N 33/566

US Classification:

435 612, 435 613, 435 71

Abstract:

A method for screening an active agent intended for preventing or combating the cutaneous signs resulting from a non-pathological impairment of the barrier function, which includes the selection of active agents that stimulate the expression of ARNT2 in cultured human keratinocytes.

US Patent:

20120244545, Sep 27, 2012

Filed:

Dec 3, 2010

Appl. No.:

13/514412

Inventors:

Alexandra D'Arcangelis - Randolph NJ, US
Elena Fedorova - Whippany NJ, US

International Classification:

C12Q 1/02
G01N 33/53
C12Q 1/68

US Classification:

435 612, 435 71, 435 29

Abstract:

A method for screening an active agent intended for preventing or combating the cutaneous signs resulting from a non-pathological impairment of barrier function, which includes the selection of active agents that stimulate the expression of the ceramide transport protein CERT in cultured human keratinocytes.

US Patent:

20100159045, Jun 24, 2010

Filed:

May 13, 2008

Appl. No.:

12/664128

Inventors:

Christelle Lasserre - Jersey City NJ, US
Elena Fedorova - Whippany NJ, US
Yannick Maestro - Martigues, FR

Assignee:

CHANEL PARFUMS BEAUTE - Neuilly Sur Seine

International Classification:

A61K 36/48
A61Q 19/00

US Classification:

424778

Abstract:

A cosmetic process for caring for human skin, intended for preventing or combating the cutaneous signs resulting from non-pathological impairment of the barrier function, includes the topical application to the skin of a composition containing at least one active agent for stimulating the expression of FN3K and/or FN3K RP. The use of this active agent for preventing or combating the cutaneous signs resulting from non-pathological impairment of the barrier function is also disclosed.